Alyssa Larson

Alyssa Larson has a multidisciplinary background spanning scientific research, healthcare investing, and investor relations. She is currently a Director of Investor Relations at RA Capital Management, where she builds relationships with current and prospective investors and helps communicate the firm’s investment strategy and scientific perspective. Earlier in her tenure at RA Capital, Alyssa was a member of the firm’s TechAtlas team, where she evaluated emerging technologies and companies across the biotechnology sector and led research initiatives supporting investment decisions. Prior to joining RA Capital, she was a Senior Scientist at Eagle Pharmaceuticals and began her career as a scientist at Arsia Therapeutics. Alyssa holds a BS in Biochemistry from the University of California, Santa Barbara and a PhD in Biochemistry from the Massachusetts Institute of Technology.